Literature DB >> 21913036

Correlation of protease-activated receptor-2 expression and synovitis in rheumatoid and osteoarthritis.

Alistair G Tindell1, Elizabeth B Kelso, William R Ferrell, John C Lockhart, David A Walsh, Lynette Dunning, Iain B McInnes.   

Abstract

Protease-activated receptor-2 (PAR-2) is known to be pro-inflammatory and increasing evidence points to an inflammatory component in osteoarthritis. This investigation examined the relationship between synovitis and PAR-2 expression, histological and immunohistochemical analysis being performed on synovial samples obtained from OA and RA patients, along with non-arthritic samples obtained by post mortem (PM). Samples were also analysed for PAR-4 expression, this receptor also having putative pro-inflammatory roles. Analysis involved comparison of inflammatory indices (synovial thickness and monocyte infiltration) with expression of PAR-2 and PAR-4. Synovial explants were also analysed for TNFα generation in the presence of a PAR-2 antagonist (ENMD-1068) or vehicle. OA synovia showed heterogeneity of inflammatory indicators, some samples overlapping with those from the RA cohort whilst others appeared similar to the PM cohort. PAR-2 expression, both in the lining layer and the interstitium, correlated strongly and significantly with synovial thickness (r = 0.91) and monocyte infiltration (r = 0.83), respectively (P < 0.001 in both cases), and this remains significant on individual cohort analysis. PAR-2 was co-localised to CD3 and CD68 cells in RA and OA synovium as well as fibroblasts derived from these synovia. PAR-4 was also expressed, but the relationship with inflammatory indicators was substantially weaker. Inflammatory indicators in OA synovia showed considerable variability, but correlated strongly with PAR-2 expression, suggesting PAR-2 upregulation in synovitis. Heterogeneity of inflammatory indicators was paralleled by wide variation in TNFα generation between samples. Secretion of this cytokine was dose-dependently inhibited by ENMD-1068, providing evidence of a functional role for PAR-2 in promoting synovitis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913036     DOI: 10.1007/s00296-011-2102-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  44 in total

Review 1.  International Union of Pharmacology. XXVIII. Proteinase-activated receptors.

Authors:  Morley D Hollenberg; Steven J Compton
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

2.  Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1beta, TNF-alpha and TGF-beta.

Authors:  Y Xiang; K Masuko-Hongo; T Sekine; H Nakamura; K Yudoh; K Nishioka; T Kato
Journal:  Osteoarthritis Cartilage       Date:  2006-06-06       Impact factor: 6.576

3.  Up-regulation of protease-activated receptor-2 by bFGF in cultured human synovial fibroblasts.

Authors:  Kazuki Abe; Akhmed Aslam; Andrew F Walls; Toshitsugu Sato; Hideo Inoue
Journal:  Life Sci       Date:  2006-05-09       Impact factor: 5.037

4.  Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1{beta}.

Authors:  Ulrika Johansson; Charlotte Lawson; Michael Dabare; Denise Syndercombe-Court; Adrian C Newland; Gareth L Howells; Marion G Macey
Journal:  J Leukoc Biol       Date:  2005-07-06       Impact factor: 4.962

5.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

6.  Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4.

Authors:  Nathalie Vergnolle; Claudia K Derian; Michael R D'Andrea; Martin Steinhoff; Patricia Andrade-Gordon
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

7.  Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo.

Authors:  Morley D Hollenberg; Mahmoud Saifeddine; Sabrina Sandhu; Steeve Houle; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2004-09-27       Impact factor: 8.739

Review 8.  Evolving concepts of rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

9.  Inflammation and angiogenesis in osteoarthritis.

Authors:  L Haywood; D F McWilliams; C I Pearson; S E Gill; A Ganesan; D Wilson; D A Walsh
Journal:  Arthritis Rheum       Date:  2003-08

10.  Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis.

Authors:  Shunji Nakano; Takuya Mishiro; Shigeyuki Takahara; Hiromichi Yokoi; Daisuke Hamada; Kiminori Yukata; Yoichiro Takata; Tomohiro Goto; Hiroshi Egawa; Susumu Yasuoka; Harumi Furouchi; Katsuya Hirasaka; Takeshi Nikawa; Natsuo Yasui
Journal:  Clin Rheumatol       Date:  2007-01-05       Impact factor: 3.650

View more
  10 in total

1.  PAR(2) expression in peripheral blood monocytes of patients with rheumatoid arthritis.

Authors:  A Crilly; E Burns; M B Nickdel; J C Lockhart; M E Perry; P W Ferrell; D Baxter; J Dale; L Dunning; H Wilson; J S Nijjar; J A Gracie; W R Ferrell; I B McInnes
Journal:  Ann Rheum Dis       Date:  2012-01-30       Impact factor: 19.103

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  TRPV4 as a therapeutic target for joint diseases.

Authors:  Amy L McNulty; Holly A Leddy; Wolfgang Liedtke; Farshid Guilak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-18       Impact factor: 3.000

Review 4.  Proteinases and their receptors in inflammatory arthritis: an overview.

Authors:  Katerina Oikonomopoulou; Eleftherios P Diamandis; Morley D Hollenberg; Vinod Chandran
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

5.  Immunomodulatory role of proteinase-activated receptor-2.

Authors:  Anne Crilly; Helen Palmer; Mohammad B Nickdel; Lynette Dunning; John C Lockhart; Robin Plevin; Iain B McInnes; William R Ferrell
Journal:  Ann Rheum Dis       Date:  2012-05-06       Impact factor: 19.103

6.  Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology.

Authors:  Carmen Huesa; Ana C Ortiz; Lynette Dunning; Laura McGavin; Louise Bennett; Kathryn McIntosh; Anne Crilly; Mariola Kurowska-Stolarska; Robin Plevin; Rob J van 't Hof; Andrew D Rowan; Iain B McInnes; Carl S Goodyear; John C Lockhart; William R Ferrell
Journal:  Ann Rheum Dis       Date:  2015-12-23       Impact factor: 19.103

7.  PAR2 regulates regeneration, transdifferentiation, and death.

Authors:  Ron Piran; Seung-Hee Lee; Pia Kuss; Ergeng Hao; Robbin Newlin; José Luis Millán; Fred Levine
Journal:  Cell Death Dis       Date:  2016-11-03       Impact factor: 8.469

Review 8.  Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology.

Authors:  Kendal McCulloch; Sarah McGrath; Carmen Huesa; Lynette Dunning; Gary Litherland; Anne Crilly; Leif Hultin; William R Ferrell; John C Lockhart; Carl S Goodyear
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-23       Impact factor: 5.555

9.  Proteinase-Mediated Macrophage Signaling in Psoriatic Arthritis.

Authors:  Fatima Abji; Mozhgan Rasti; Alejandro Gómez-Aristizábal; Carla Muytjens; Mahmoud Saifeddine; Koichiro Mihara; Majid Motahhari; Rajiv Gandhi; Sowmya Viswanathan; Morley D Hollenberg; Katerina Oikonomopoulou; Vinod Chandran
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

10.  The activation fragment of PAR2 is elevated in serum from patients with rheumatoid arthritis and reduced in response to anti-IL6R treatment.

Authors:  Stefania Kalogera; Yi He; Anne-Christine Bay-Jensen; Thorbjørn Gantzel; Shu Sun; Tina Manon-Jensen; Morten Asser Karsdal; Christian S Thudium
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.